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Abstract
From the relatively simple nervous system of   to the elaborateDrosophila
mammalian cortex, neurogenesis requires exceptional spatial and temporal
precision to co-ordinate progenitor cell proliferation and subsequent
differentiation to a diverse range of neurons and glia. A limited number of
transiently expressed proneural basic-helix-loop-helix (bHLH) transcription
factors, for example   and   in achaete-scute-complex (as-c) atonal (ato)
 and the vertebrate homologues Ascl1 and Neurogenin2 (Ngn2), areDrosophila
able to orchestrate the onset of neuronal determination, context-dependent
subtype selection and even influence later aspects of neuronal migration and
maturation. Within the last decade, two models have emerged to explain how
the temporal activity of proneural determination factors is regulated by
phosphorylation at distinct sites. One model describes how cell-cycle
associated phosphorylation on multiple sites in the N and C termini of
vertebrate proneural proteins limits neuronal differentiation in cycling progenitor
cells. A second model describes phosphorylation on a single site in the bHLH
domain of   that acts as a binary switch, whereDrosophila atonal
phosphorylation terminates proneural activity. Here we combine activating
mutations of phosphorylation sites in the N- and C- termini with an inhibitory
phospho-mimetic mutation in the bHLH domain of Ascl1 and Ngn2 proteins,
and test their functions   using   embryos to determine whichin vivo Xenopus
mode of phospho-regulation dominates. Enhancing activity by preventing N-
and C terminal phosphorylation cannot overcome the inhibitory effect of
mimicking phosphorylation of the bHLH domain. Thus we have established a
hierarchy between these two modes of proneural protein control and suggest a
model of temporal regulation for proneural protein activity.
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Introduction
Development of the nervous system requires elaborate control 
to expand progenitor cells before subsequent differentiation 
into a diverse array of neuronal and glial subtypes. One of the 
most striking features is that a limited number of proneural 
basic-helix-loop-helix (bHLH) determinant factors, for example 
achaete-scute-complex (as-c) and atonal (ato) in Drosophila 
and the vertebrate homologues Ascl1 and Neurogenin2 (Ngn2), 
are able to orchestrate both generic neuronal determination and 
context-dependent neuronal subtype selection1. Furthermore, 
these determination factors are able to influence relatively late 
aspects of neuronal migration and maturation despite having 
only a transient window of expression1. Proneural protein activity 
is exquisitely regulated both spatially and temporally2,3, and 
mechanisms are conserved from Drosophila neurogenesis to 
the mammalian cortex.
The mechanisms that underlie the complexity of the develop-
ing nervous system have begun to be elucidated. For example 
there are multiple bi-directional links that intimately connect and 
influence the transition between progenitor cell proliferation 
and neuronal differentiation during neurogenesis4. Within the 
last decade, models of phospho-regulation have emerged to 
explain the temporal control and/or context-dependent activity 
of proneural determination factors5–7. Modification of single 
regulatory phospho-sites may fine-tune activity of individual 
proneural proteins within a given context, for example GSK3β-
mediated phosphorylation of Ngn2 to promote motor neuron 
formation8. Additionally, models have been described to regulate 
generic proneural activity in progenitor cells.
Firstly, a multi-site phospho-regulatory model is described for 
vertebrate Ascl1 and Ngn2, based on data from Xenopus 
embryos and mammalian cell culture5,6,9,10. Cyclin-dependent- 
kinase activity that promotes the cell cycle can additionally 
phosphorylate proneural proteins on multiple Serine-Proline 
sites located in the N and C termini either side of the basic 
helix-loop-helix domain that regulates DNA binding and dim-
erisation. This multi-site phosphorylation limits protein stability 
and chromatin association, and specifically reduces activation 
of genes associated with cell cycle exit and differentiation5,6. 
Correspondingly, Serine to Alanine phospho-mutant prone-
ural proteins that cannot undergo this phosphorylation promote 
differentiation during development, and in cellular reprogram-
ming assays5,6,9.
Secondly, a single regulatory phospho-site within the bHLH 
domain is described for atonal in Drosophila retina and Ngn2 
in mouse cortex; while the phospho-mutant versions behave 
as the wild-type proteins, the respective Serine/Threonine to 
Aspartic acid phospho-mimetics are inactive7. Phosphorylation 
of this single site in atonal acts a binary switch to terminate 
proneural activity in retinal R8 precursors7. Here we present a 
short study to determine the effect of combining the activating 
mutations blocking phosphorylation of the N and C-termini of 
mouse Ascl1 and Ngn2 with an inhibitory phospho-mimetic 
mutation in the bHLH domain, to determine whether one mode 
of phospho-regulation is dominant over the other.
Methods
Animal care
All work has been carried out under UK Home Office Licence 
and has passed an Institutional ethical review committee assess-
ment at the University of Cambridge.
Plasmids and constructs
Wild-type mouse Ascl1 (Genbank accession number NM008553) 
and 6S-A phospho-mutant mouse Ascl1 were published in 9. 
Wild-type mouse Ngn2 (Genbank accession number NM009718) 
and 9S-A mouse Ngn2 were published in 5. The S150D and 
T149D substitutions were introduced by Quikchange II site 
directed mutagenesis (Agilent Technologies). Primers:
mAscl1_S150D_S = CGGCCAACAAGAAGATGGACAAGGT-
GGAGACGCTGC;
AS = GCAGCGTCTCCACCTTGTCCATCTTCTTGTTGGCCG.
mNgn2_T149D_S = CCGAGGATGCCAAGCTCGATAAGATC-
GAGACGCTGCG,
AS = CGCAGCGTCTCGATCTTATCGAGCTTGGCATC-
CTCGG.
Xenopus laevis embryo manipulation
All efforts are made to ameliorate suffering to any animal. 
For example, the colony of approximately 80 X. laevis females 
are housed and cared for by a dedicated team of animal 
technicians operating under Home Office Licence. Each 
experiment requires eggs from 2 or 3 females (depending on 
N = 2 or 3) and females are used on rotation within the 
colony with at least a 3-month rest period after laying. A single 
male frog is sacrificed under humane conditions and Home 
Office Licence to provide testes for at least 16 experiments. 
Embryos obtained from fertilised eggs are used for the experi-
ments and development is stopped 48 hours post fertilisation 
when embryos reach late neurula stage and prior to formation of 
tadpoles.
Thus, X. laevis eggs were obtained by standard hormone 
methods of induction, and subsequently fertilised in vitro. pCS2+ 
constructs were linearised and capped mRNA was transcribed 
in vitro using the SP6 mMessage mMachine® kit (Ambion). 
Embryos were injected unilaterally at the two cell stage with 
mRNA as indicated in the text, with GFP (for qPCR) or β-gal 
(ISH) as lineage tracers. Embryos were cultured at 18°C in Ficol 
solution and staged according to 11. At stage 18, embryos were 
either snap-frozen for qPCR analysis or fixed in MEMFA for 
90 minutes, as described in 12.
Whole mount in situ hybridisation (ISH)
Dig-oxigenin-labelled anti-sense probes were synthesised 
from plasmid X. laevis neural-β-tubulin13. Whole mount ISH 
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was performed as described in 12 and embryos were scored for 
the extent and pattern of gene expression as described in data 
analysis.
Quantitative real-time PCR (qPCR)
GFP expression was used to confirm successful injection and 
samples of four embryos were snap frozen. Whole embryo 
RNA was extracted using the RNeasy® Mini kit (Qiagen) and 
template cDNAs synthesised with the QuantiTect® Reverse 
Transcription Kit (Qiagen). qPCR was performed using the 
Quantifast® SYBR Green PCR kit (Qiagen) in a LightCycler® 
480 (Roche). Thermal cycling conditions: 95°C for 5 minutes, 
then 45 cycles of 95°C for 10s, 60°C for 10s and 72°C for 20s. 
EF1α reference gene (Genbank accession NM001087442): 
Forward, CACCATGAAGCCCTTACTGAG; Reverse, TGA-
TAACCTGTGCGGTAAATG. N-β-Tubulin target gene (Genbank 
accession NM001086064): Forward, TGGATTTGGAACCAG-
GCA; Reverse, GCTCAGCTCCTTCGGTGTA.
Western blotting
For western blot analysis, 12 embryos were snap frozen at stage 
11 and whole embryo protein was extracted as described in 12. 
50µg total protein was loaded on to pre-cast BioRad Criterion™ 
TGX 18% gels in Tris-Glycine buffer. Primary antibodies were 
used at 1:2000 dilution for at least 1 hour at room tempera-
ture (tubulin) or at 4°C overnight (HA): Rat HRP-conjugated 
anti-HA clone 3F-10 antibody (Roche; 12013819001) and 
mouse anti-α-tubulin clone B-5-1-2 antibody (Sigma; T5618). 
Anti-tubulin antibody was detected with a sheep HRP-conju-
gated anti-mouse antibody at 1:10000 dilution (GE Healthcare; 
NA931V).
Data analysis
For ISH data, embryos were scored for the extent and pattern 
of N-β-Tubulin expression on the injected side relative to 
uninjected side and to uninjected embryos. Scores were assigned 
as 0, no difference; +1, mild increase in expression within the 
neural tube with or without occasional ectopic expression on 
the injected side; +2, moderate increase with ectopic expression 
occurring in patches on the injected side and sometimes bilater-
ally; +3, substantial increase with extensive ectopic expression 
in a more homogenous pattern on the injected side and some-
times bilaterally. Experiments were conducted in independent 
duplicate and the N numbers refer to the range of total numbers 
of embryos in each injection category.
For qPCR data, mRNA expression was normalised to expres-
sion of reference gene EF1α and mRNA levels in the injected 
embryos were calculated relative to stage-matched uninjected 
controls. Mean values are plotted and error bars show the 
standard error of the mean from two independent experiments. 
Statistical significance was calculated by a paired two-tailed 
student T test in Microsoft Excel 2010; NS = not significant; 
* = p< 0.05; ** = p< 0.025; *** = p< 0.0125. Western blot is 
representative from two independent experiments. For protein 
quantification, Image J software was used as described in 12.
Results
Generation of combined phospho-mutant and phospho-
mimetic constructs
Experiments supporting the regulatory model based on multi-site 
phosphorylation in the N- and C-termini of proneural proteins 
has been well documented in Xenopus, mouse and human 
proneural proteins5,6,9,10,12, with conservation of the model across 
germ layers to include bHLH proteins in other tissues such as 
MyoD in muscle/mesoderm14 and Ngn3 in pancreas/endoderm15. 
In each case, the regulatory phospho-sites are located in the N 
and C terminal domains, and preventing phosphorylation by 
mutating Serine/Threonine-Proline sites to Alanine-Proline results 
in enhanced protein stability and increased DNA binding affinity. 
This enables expression of slower responding differentiation 
genes that tend to be less epigenetically available; reviewed in 16. 
Hence de-phosphorylation of these sites enhances the ability of 
bHLH proteins to drive differentiation.
In contrast, phosphorylation of a single site in the bHLH 
domain of Drosophila atonal in the R8 photoreceptors of the 
Drosophila retina terminates proneural activity, and this mode 
of regulation appears to be conserved with Ngn2 in murine 
cortical progenitors7. This single conserved site at the junction 
between the loop region and helix 2 is predicted to lie in the near 
vicinity of negatively charged phosphates in the DNA backbone; 
phosphorylation of the site, possibly mediated by Protein Kinase 
A, reduces DNA binding to inactivate atonal upon R8 precursor 
selection7.
The effect of manipulating the single bHLH domain regulatory 
site has not previously been investigated in mouse Ascl1 pro-
tein (homologue of Drosophila as-c), nor has the effect of 
modulation been tested in the Xenopus system. Hence, in the 
present study, the equivalent phospho-mimetic construct was 
made with substitution of Serine 150 to Aspartic acid (S150D) in 
wild-type (WT) mAscl1. To explore the effect of combining this 
potentially inactivating mutation with activating mutations that 
prevent phosphorylation on multiple N- and C-terminal sites, 
the same S150D phospho-mimetic substitution was made into 
6S-A mAscl1, where six Serine-Proline (SP) sites in the N and 
C termini have been mutated to Alanine-Proline (Figure 1A). In 
addition, a Threonine 149 phospho-mimetic (T149D) form of 
mNgn27 was recreated in both a wild-type and a 9S-A Ngn2 
background, where nine Serine-Proline (SP) sites in the N and 
C termini of mNgn2 have been mutated to Alanine-Proline5 
(Figure 2A). All constructs contain a single C terminal HA tag.
The single-site bHLH phospho-mimetic within the bHLH 
domain inactivates Ascl1 activity
Early development of Xenopus laevis is an excellent in vivo 
assay system in which to explore proneural protein activity; 
over-expression of proteins such as Ascl1 and Ngn2 by micro-
injection of in vitro transcribed mRNA results in induced 
neurogenesis and expression of neural-β-tubulin across the lateral 
ectoderm5,6. Initially focusing on Ascl1, to confirm protein 
expression whole embryo extracts were made from embryos 
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Figure 1. S150D single site mutation inactivates both WT and 6S-A Ascl1. (A) Schematic representation of WT Ascl1 and the three mutant 
constructs tested. The relative location of the S150D phospho-mimetic substitution within the bHLH domain is indicated (blue), along with the 
location of the six Serine to Alanine phospho-mutant substitutions in the N and C termini (red). (B) Western blot analysis of stage 11 whole 
embryo extracts over-expressing 200pg of each construct, with tubulin as a loading control. All four constructs are expressed in embryos 
and the additional S150D mutation has no significant effect on WT or 6S-A Ascl1 protein migration or accumulation. (C–E) Two cell stage 
embryos were unilaterally injected with 40pg of mRNA encoding each construct. At stage 18, embryos were assayed for expression of 
neural-β-tubulin relative to uninjected control embryos. (C) qPCR data [N=2] with significance calculated by paired student T test; * = 
p< 0.05. (D) Semi-quantitative scoring of grade of neurogenesis after ISH [N=53-73 embryos per category from two experiments]. 
(E) Representative images of embryos with injected side to the right, stained with pale blue β-gal tracer. Induction of neural-β-tubulin by WT 
and 6S-A Ascl1 is prevented with the respective introduction of the single S150D mutation.
over-expressing equal amounts of mRNA encoding each of the 
four Ascl1 constructs (Figure 1A, B). All four constructs are 
successfully expressed in Xenopus embryos: WT Ascl1 and 
S150D Ascl1 migrate as broad bands while 6S-A Ascl1 and 
6S-A/S150D Ascl1 appear as single faster migrating bands, 
consistent with the former pair being phosphorylated on the 
sites mutated in the latter pair.
Additionally, 6S-A Ascl1-based proteins accumulate more 
than the respective WT proteins, consistent with an increase in 
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Figure 2. T149D single site mutation significantly inhibits both WT and 9S-A Ngn2. (A) Schematic representation of WT Ngn2 and the 
three mutant constructs tested. The relative location of the T149D phospho-mimetic substitution within the bHLH domain is indicated (blue), 
along with the location of the nine Serine to Alanine phospho-mutant substitutions in the N and C termini (red). (B–D) Two cell stage embryos 
were unilaterally injected with 25pg of mRNA encoding each construct. At stage 18, embryos were assayed for expression of neural-β-tubulin 
relative to uninjected control embryos. (B) qPCR data [N=2] with significance calculated by paired student T test; * = p< 0.05; *** = p< 0.0125. 
(C) Semi-quantitative scoring of grade of neurogenesis after ISH [N=36–39 embryos per category from two experiments]. (D) Representative 
images of embryos with injected side to the right, stained with pale blue β-gal tracer. Introduction of the T149D mutation prevents induction 
of neural-β-tubulin by WT Ngn2 and significantly inhibits 9S-A Ngn2.
protein half-life of this phospho-mutant6. While there is a trend 
towards a reduced protein density in 6S-A/S150D compared to 
6S-A Ascl1, when measured relative to the tubulin loading 
control from repeat experiments, the difference between these 
is not statistically significant (p=0.078). Thus, the introduction 
of the S150D phospho-mimetic into the WT or 6S-A Ascl1 
constructs does not significantly affect the protein accumulation.
To test for functional effects of these different forms of Ascl1, 
mRNA encoding each construct was unilaterally injected into 
two cell stage embryos, and neurogenesis was assayed at stage 
18 by qPCR or in situ hybridisation (ISH) for expression of 
N-β-tubulin (Figure 1C–E), a marker of primary neurogenesis. 
As previously reported, over-expression of both WT and 6S-A 
Ascl1 induces ectopic neurogenesis on the injected side both 
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within and outside the neural plate6. In direct comparison, 
6S-A Ascl1 shows enhanced proneural activity relative to WT 
Ascl1, inducing N-β-tubulin expression more extensively over 
the lateral ectoderm and three-fold higher transcript accumula-
tion by qPCR analysis. In contrast, the introduction of the single 
S150D phospho-mimetic dramatically inactivates both WT and 
6S-A Ascl1, consistent with inhibition of DNA binding as 
described previously7. If so, this suggests that the superior activity 
of 6S-A relative to WT Ascl1 requires direct DNA binding.
The single-site bHLH phospho-mimetic inactivates Ngn2 
activity
To complement these experiments with Ascl1, we undertook 
a comparable analysis, investigating the activity of WT and 
9S-A mouse Ngn2 with and without the T149D substitution in 
the bHLH domain5,7. Ngn2 is more potent than Ascl1 in upregu-
lating N-β-tubulin in Xenopus embryos. Hence, mRNA quantities 
for injection were reduced to 25pg with assay of N-β-tubulin 
induction as before (Figure 2B–D). Both WT and 9S-A 
Ngn2 induce extensive ectopic expression of N-β-tubulin 
within and outside the neural plate, and on qPCR analysis, 
9S-A Ngn2 induces approximately twice the level of N-β-tubulin 
transcripts as WT Ngn2. As with Ascl1, the introduction of the 
single T149D mimetic strikingly inhibits the ability of both 
WT and 9S-A Ngn2 to induce ectopic neurons. However, in 
contrast to Ascl1, some residual activity is maintained in 
9S-A/T149D Ngn2 but this is reduced to expansion of the neural 
tube only rather than induction of ectopic neurogenesis.
Discussion/conclusions
In this study, we firstly demonstrate that introduction of a 
single phospho-mimetic residue into the bHLH domain of 
mouse Ascl1 inactivates its ability to drive neurogenesis, as 
previously described in Drosophila atonal7. We next inves-
tigated Ascl1 and Ngn2 proneural activity in the presence of 
activating mutations in the N- and C-termini5,6, together with 
inhibitory phospho-mimetic mutation in the bHLH domain7. 
We find that inhibition of proneural activity by this inhibitory 
phospho-mimetic mutation is dominant. S/T-D substitutions in 
the bHLH domain reduce DNA binding of the proneural protein7 
so it is reasonable to assume that S-A mutant Ascl1 and Ngn2 
require DNA binding for their enhanced activity in Xenopus, but 
we have not tested this hypothesis directly. It would be interest-
ing to determine whether residual activity in the 9S-A/T149D 
mutant of Ngn2 represents residual DNA binding or acts via a 
DNA-binding independent mechanism, e.g. by complexing with 
other DNA-bound factors.
The binary switch model where a single phosphorylation event 
in the bHLH domain controls DNA binding is an elegant way 
to achieve a rapid and sharp change in proneural activity in 
response to the cellular environment that is not dependent on 
protein degradation or subcellular translocation7. In contrast, 
multi-site phosphorylation of the N- and C-termini works 
much more like a rheostat where decreasing levels of Cyclin- 
dependent-kinase activity at the transition towards differen-
tiation leads to a more gradual change in phospho-status and 
proneural activity5,6. Combining both models, a temporal scheme 
could be suggested where sequential kinase activity exquisitely 
controls neurogenesis. In actively proliferating neural progenitor 
cells, proneural activity may be restrained by multi-site phospho-
rylation of proneural factors by Cyclin/Cyclin-dependent-kinases 
to enable sufficient progenitor cell expansion. At the transition 
to differentiation, where the cell cycle slows and lengthens, 
gradual de-phosphorylation of proneural proteins may tip the 
balance in favour of differentiation and activation of down-
stream gene cascades required to drive neurogenesis. Once these 
cascades are activated, determination proneural factor activ-
ity could be rapidly halted by phosphorylation of the bHLH 
domain, possibly by PKA or other later acting kinases7. In this 
way, combining these two modes of phospho-regulation in 
proneural proteins could provide an explanation for temporal 
regulation of generic proneural determination activity from 
proliferating progenitor cells through to differentiating neurons.
Data availability
Raw data files available in Open Science Framework: Interaction 
between opposing modes of phospho-regulation of the prone-
ural proteins Ascl1 and Ngn2, https://doi.org/10.17605/OSF.
IO/73NE517
See Methods section for description of data analysis and ISH 
scoring. Datasets presented are as follows:
-    Fig1B_WesternBlot with Fig1B_Loading
-    Fig1C_qPCR: Mean fold change in N-β-tubulin expres-
sion relative to uninjected controls; two independent 
experiments.
-    Fig1D_ISH: Semi-quantitative scoring of extent of 
neurogenesis for each injection category showing total 
number of embryos from two independent experiments.
-    Fig1E_embryos: Representative images from 53–73 
embryos in each category in two independent experiments.
-    Fig2B_qPCR: Mean fold change in N-β-tubulin expres-
sion relative to uninjected controls; two independent 
experiments.
-    Fig2C_ISH: Semi-quantitative scoring of extent of 
neurogenesis for each injection category showing total 
number of embryos from two independent experiments.
-    Fig2D_embryos: Representative images from 36–39 
embryos in each category in two independent experiments.
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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The authors have previously shown that multi-site phosphorylation is a conserved mechanism that inhibits
the neuronal-inducing activity of the proneural bHLH proteins. Correspondingly, phospho-null mutations in
the N- and C-termini of Neurog2 and Ascl1 cumulatively increases the stability and proneural activity of
these proteins. More recently (Quan et al., 2016), it has been shown that the proneural activity of Scute
and Atonal in the  wing disc, as well as Neurog2 in the developing mouse cortex can beDrosophila 
inactivated by phosphorylation of a single conserved residue. This conserved residue is located in the
bHLH domain and its phosphorylation disrupts DNA binding.
In this short research note, Hardwick and Philpott investigated which of the afore described bHLH protein
phosphorylation mechanisms is dominant in the control of the proneural activity. The ability of the
wild-type Ascl1 and Neurog2 to promote neuronal differentiation in comparison to versions of the proteins
harboring phospho-null mutations in the N-and C-termini or a phospho-mimetic mutation in the bHLH
domain alone, as well as in combination were studied. The proneural activity was assessed in gain of
function assays using  embryos. As shown using both qPCR analysis and whole mount in situX. laevis
hybridization, the phospho-mimetic mutation in the bHLH domain of Ascl1 and Neurog2 abolished their
ability to promote neuronal differentiation. The inhibitory phospho-mimetic mutation was also able to
override the activating effect of the phospho-null mutations in the N- and C-termini of Ascl1. Neurog2,
however, still maintained weak proneural activity.
 
In general, the report is well and succinctly written, the figures are clear and represent the authors
conclusions. The report is of interest as it further demonstrates the conservation of phosphorylation in the
bHLH domain as a dominant regulatory mechanism to inhibit proneural protein activity. Introduction of the
bHLH phospho-mimetic mutation in the Neurog2 phospho-null N- and C-termini mutant (9S-A/T149D)
was not sufficient to completely disrupt neuronal differentiation induced by this mutant. These findings
complement that of Quan et al., which found that the Neurog2 bHLH phospho-mimetic mutant still
maintains weak DNA binding activity. However, alternative mechanisms cannot be excluded.
 
It will be of interest to study the phospho-null bHLH mutation in this system to further evaluate the
consequences of persistent proneural activity. 
 
Minor point: The authors state that the 9S-A/T149D Neurog2 mutant maintains residual activity, which is
restricted to the neural ectoderm. However, for the embryo depicting this activity (Fig 2D), it appears that
the injected mRNA has not targeted the nonneural ectoderm (see b-gal staining).
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 Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
 School of Medicine, University of Manchester, Manchester, UK
In this research note, the authors attempt to reconcile two different mechanisms regulating the activity of
pro-neural bHLH transcription factors. The authors have previously shown very convincingly that
Neurogenin2 and Ascl1 are phosphorylated on multiple SP sites by Cyclin Dependant Kinase 2 (Cdk2),
preventing their ability to drive neuronal differentiation. These phosphorylation sites are located in the N-
and C-terminal regions of the proteins, but not in the DNA binding domain. Furthermore, they have
previously shown that the multiple phosphorylation sites can act as a “rheostat” to regulate Ngn2/Ascl1
activity. In contrast, studies from Drosophila (atonal in the retina) and in the mouse cortex (Ngn2)
pinpoints to an on/off mechanism by a single phosphorylation event in the DNA binding domain.
Interestingly, this phosphorylation site is very well conserved in other pro-neuronal bHLH transcription
factors such as  Ascl1. The authors have therefore decided to test the possibility that both mechanisms
(rheostat and on/off switch) might co-exist to regulate the activity of pro-neural bHLH in vertebrates. 
 
Overall the manuscript is very well written, the methods are well established in the lab and the assays
used are very robust. The data support the conclusions of the study, i.e. that both mechanisms of
regulation co-exist. However, I have one major issue that the authors could address easily to improve the
validity of their conclusions. The statistical analyses of their data should be improved by doing the
following:
1,2
1
2
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 following:
- mean and standard deviation (which is more appropriated than standard error of the mean) should be
calculated on at least three repeats rather than two. 
- within an experiment where multiple conditions are compared (ie Figure 1c or 2b), a two-way ANOVA
with post-hoc test should be applied rather than multiple t-tests. 
- when categorising data (Fig1D/2C), a X should be performed.
Given the clear differences, I am sure that these analyses will not change the conclusion of the study but
there is rightly a drive for more rigorous statistical analyses of the data that are reported. 
 
One minor point that could be discussed by the authors, and maybe the subject of further studies: I would
have expected the S150D / T149D mutants to have a dominant negative effect (i.e. less neurogenesis)
but it seems that they are inert. Is it because they do not dimerise with Xenopus Ascl1 / Ngn2? Would the
authors expect the same results should they use the Xenopus orthologues?
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